Scientists have identified evidence that chronic neuroinflammatory causes neurodegeneration in Parkinson's disease (PD), according to a study published in the journal The Lancet in July, 2022, which shows the discovery of an innovative drug.
Source: markets.businessinsider.comPublished on 2022-07-27
Related news
- Replacing Wood - and Charcoal - Burning Stoves in Sub - Saharan Africa Could Avert Many Deaths
- DoD Innovate Beyond 5G Program embarks on three new projects - Military Embedded Systems
- Global Genes Announces Completion of RARE - X Merger and Strategic Direction for Combined Organization
- New Study Shows the Incidence of Parkinson Disease in the U . S . is 50 % Higher than Previous Estimates
- Northumbrian Water £6million grant to help sort out leaks
- New mobile app to reduce food waste
- $205 Million to Go to Mental - Health and Infectious - Disease Research ; Bezos Earth Fund Commits $50 Million for Marine Protection
- COVID - 19 Vaccine Booster Launch Plan Could Be Delayed
- TOMORROW x TOGETHER ( TXT ) named newest brand ambassadors of Smart
- Two years after creating a CDO position , Labor sending in extra resources
- North West Queensland copper waste could power EV revolution
- Herpesvirus triggers cervical cancer affecting nearly 1 in 4 adult sea lions
- SPIE DCS 2021 : NGA embraces historic inflection point
- Reducing the use of wood - and charcoal - burning stoves could save half a million lives in Africa